-
Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial InfarctionN Haider, L Boscá, HR Zandbergen et al. -
The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 SubstudyJ Dusek, Z Motovska, Prague-18 Study Group et al.
-
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)J-P Collet, H Thiele, E Barbato et al.
-
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary AngiographyRHM Furtado, JC Nicolau, JP Guo et al.
-
Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary InterventionYN Dai, JL Huang, DQ Yu et al.
-
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseM Bossard, P Gao, W Boden et al.
-
From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary SyndromesSzummer K, Jernberg T, Wallentin L.
-
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
